SCHEMBL594188

SCHEMBL594188

CC(CO)C(N)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4259672 1.00 — —
SCHEMBL594189 1.00 — —
Phosphoric Acid SCHEMBL1758764 0.91 SLC7A5 (0.46) —
SCHEMBL28890361 0.85 USP2 (0.57) —
SCHEMBL11855669 0.83 USP2 (0.59) —
SCHEMBL10971625 0.83 USP2 (0.59) —
SCHEMBL4755452 0.80 SLC7A5 (0.50) —
SCHEMBL1236513 0.80 SLC7A5 (0.50) —
Isoleucine SCHEMBL22807324 0.80 SLC7A5 (0.50) —
SCHEMBL1236514 0.80 SLC7A5 (0.50) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020081958-A2 COMPOSITIONS AND METHODS FOR IDENTIFYING MUTATIONS OF GENES OF MULTI-GENE SYSTEMS HAVING IMPROVED FUNCTION THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2020-04-23 — — WO claimed
US-9101662-B2 Compositions with modulating agents FOAMIX PHARMACEUTICALS LTD. (IL) 2015-08-11 — — US claimed
US-8795693-B2 Compositions with modulating agents FOAMIX LTD. (IL) 2014-08-05 — — US claimed
CN-102812038-A Treatments For Gastrointestinal Disorders IRONWOOD PHARMACEUTICALS INC 2012-12-05 — — CN claimed
EP-2097065-A2 FOAMABLE WATERLESS COMPOSITIONS WITH MODULATING AGENTS Foamix Ltd. (IL) 2009-09-09 — — EP claimed
WO-2008152444-A2 FOAMABLE WATERLESS COMPOSITIONS WITH MODULATING AGENTS FOAMIX LTD. (US) 2008-12-18 — — WO claimed
US-20080206159-A1 Drug mixture contains solvents, nonionic surfactants, gelling agent, therapeutic active agent, liquefied or compressed gas propellant; pressurized dispenser; treating skin diseases, dermal and mucosal delivery; stable and non-irritating emulsions FOAMIX LTD. (IL) 2008-08-28 — — US claimed
US-5658885-A OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1997-08-19 — — US claimed
CN-118159298-A Method for producing antibody-linker conjugates 阿拉里斯生物技术股份公司 2024-06-07 — — CN disclosed
CN-116406302-A Method of transglutaminase conjugation with amino acid based linkers 阿拉里斯生物技术股份公司 2023-07-07 — — CN disclosed
US-20230151394-A1 BIOLOGIC SYNTHESIS OF DIOLS FROM AMINO ACIDS Taizhou Simplu Technology Co., Ltd. (CN) 2023-05-18 — — US disclosed
US-20230151394-A1 BIOLOGIC SYNTHESIS OF DIOLS FROM AMINO ACIDS Taizhou Simplu Technology Co., Ltd. (CN) 2023-05-18 — — US disclosed
US-20230151394-A1 BIOLOGIC SYNTHESIS OF DIOLS FROM AMINO ACIDS Taizhou Simplu Technology Co., Ltd. (CN) 2023-05-18 — — US disclosed
EP-4127197-A1 BIOLOGIC SYNTHESIS OF DIOLS FROM AMINO ACIDS Taizhou Simplu Technology Co., Ltd. (CN) 2023-02-08 — — EP disclosed
WO-2001064678-A2 INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2001-09-07 — — WO disclosed
WO-2001040262-A1 ALPHA-KETOAMIDE INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2001-06-07 — — WO disclosed
WO-2001002424-A2 PEPTIDE BORONIC ACID INHIBITORS OF HEPATITIS C VIRUS PROTEASE DU PONT PHARMACEUTICALS COMPANY (US) 2001-01-11 — — WO disclosed
US-5658885-A OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1997-08-19 — — US disclosed
EP-0787010-A1 AMIDINO AND GUANIDINO SUBSTITUTED INHIBITORS OF TRYPSIN-LIKE ENZYMES THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1997-08-06 — — EP disclosed
WO-1996012499-A1 AMIDINO AND GUANIDINO SUBSTITUTED INHIBITORS OF TRYPSIN-LIKE ENZYMES THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-05-02 — — WO disclosed
Send feedback